Abstract
TP53 has been reported to be involved in diverse neurological processes related to the pathogenesis of psychosis. In this study, we aim to determine the association of TP53 polymorphisms, rs1042522 and rs17879353, with the susceptibility to schizophrenia (SCZ) or bipolar disorder (BD) in Chinese Han population. A total of 548 SCZ patients, 512 BD patients, and 598 healthy controls were recruited. Genotyping was conducted through Sequenom MassARRAY technology platform. The quantitative real-time polymerase chain reaction (qRT-PCR) was used to detect TP53 expression level. Results revealed that the allele frequency and genotype distribution of rs1042522 within BD patients were significantly different from those of the controls. Rs1042522 was significantly associated with BD risk under diverse genetic models. However, no significant association was found for rs17879353 and BD risk and for rs1042522 and rs17879353 and SCZ risk. TP53 expression was significantly increased in SCZ patients and BD patients compared with that in the controls but was significantly decreased in BD patients with CC genotype of rs1042522 compared with that in other BD patients with either CG or GG genotype. In summary, we observed for the first time that rs1042522 is significantly associated with BD risk in the Chinese Han population. The increased TP53 expression might affect the occurrence of BD and SCZ, and rs1042522 might affect the progress of BD by disturbing gene expression.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Abdel-Aziz MM, Elshal MF, Abass AT, El-Kafrawy S, Ezzat S, Abdel-Wahab M (2016) Comparison of AFP-L3 and p53 antigen concentration with alpha-fetoprotein as serum markers for hepatocellular carcinoma. Clin Lab 62:1121–1129
Allen NC, Bagade S, McQueen MB, Ioannidis JPA, Kavvoura FK, Khoury MJ, Tanzi RE, Bertram L (2008) Systematic meta-analyses and field synopsis of genetic association studies in schizophrenia: the SzGene database. Nat Genet 40:827–834. https://doi.org/10.1038/ng.171
Aloyz RS, Bamji SX, Pozniak CD, Toma JG, Atwal J, Kaplan DR, Miller FD (1998) p53 is essential for developmental neuron death as regulated by the TrkA and p75 neurotrophin receptors. J Cell Biol 143:1691–1703
Armstrong JF, Kaufman MH, Harrison DJ, Clarke AR (1995) High-frequency developmental abnormalities in p53-deficient mice. Current biology: CB 5:931–936
Benes FM, Walsh J, Bhattacharyya S, Sheth A, Berretta S (2003) DNA fragmentation decreased in schizophrenia but not bipolar disorder. Arch Gen Psychiatry 60:359–364. https://doi.org/10.1001/archpsyc.60.4.359
Birnbaum R, Weinberger DR (2017) Genetic insights into the neurodevelopmental origins of schizophrenia. Nat Rev Neurosci 18:727–740. https://doi.org/10.1038/nrn.2017.125
Buoli M, Serati M, Caldiroli A, Cremaschi L, Altamura AC (2017) Neurodevelopmental versus neurodegenerative model of schizophrenia and bipolar disorder: comparison with physiological brain development and aging. Psychiatr Danub 29:24–27
Burmeister M, McInnis MG, Zollner S (2008) Psychiatric genetics: progress amid controversy. Nat Rev Genet 9:527–540. https://doi.org/10.1038/nrg2381
Cai X, Qian C, Wu W, Lei H, Ding Q, Zou W, Xiang D, Wang X (2017) An exonic missense mutation c.28G>A is associated with weak B blood group by affecting RNA splicing of the ABO gene. Transfusion 57:2140–2149. https://doi.org/10.1111/trf.14209
Cannon TD, Kaprio J, Lonnqvist J, Huttunen M, Koskenvuo M (1998) The genetic epidemiology of schizophrenia in a Finnish twin cohort. A population-based modeling study. Arch Gen Psychiatry 55:67–74
Catts VS, Catts SV (2000) Apoptosis and schizophrenia: is the tumour suppressor gene, p53, a candidate susceptibility gene? Schizophr Res 41:405–415
Cheng C, Lingyan W, Yi H, Cheng Z, Huadan Y, Xuting X, Leiting X, Meng Y, Shiwei D (2014) Association between TLR2, MTR, MTRR, XPC, TP73, TP53 genetic polymorphisms and gastric cancer: a meta-analysis. Clin Res Hepatol Gastroenterol 38:346–359. https://doi.org/10.1016/j.clinre.2013.12.009
Chiu HJ, Wang YC, Chen JY, Hong CJ, Tsai SJ (2001) Association study of the p53-gene Pro72Arg polymorphism in schizophrenia. Psychiatry Res 105:279–283
Ding WJ, Zeng T, Wang LJ, Lei HB, Ge W, Wang Z (2017) Genes with mutation significance were highly associated with the clinical pattern of patients with breast cancer. Oncotarget 8:98094–98102. https://doi.org/10.18632/oncotarget.21453
Donadon I, McVey JH, Garagiola I, Branchini A, Mortarino M, Peyvandi F, Bernardi F, Pinotti M (2018) Clustered F8 missense mutations cause hemophilia A by combined alteration of splicing and protein biosynthesis and activity. Haematologica 103:344–350. https://doi.org/10.3324/haematol.2017.178327
Dumont P, Leu JI, Della Pietra AC 3rd, George DL, Murphy M (2003) The codon 72 polymorphic variants of p53 have markedly different apoptotic potential. Nat Genet 33:357–365. https://doi.org/10.1038/ng1093
Fan S, Hao ZY, Zhang M, Liang CZ (2017) Association between the rs1042522 polymorphism in TP53 and prostate cancer risk: an updated meta-analysis. Chronic Dis Transl Med 3:95–104. https://doi.org/10.1016/j.cdtm.2017.04.001
Gao M, Zhao LR (2018) Turning death to growth: hematopoietic growth factors promote neurite outgrowth through MEK/ERK/p53 pathway. Mol Neurobiol 55:5913–5925. https://doi.org/10.1007/s12035-017-0814-x
Geske FJ, Nelson AC, Lieberman R, Strange R, Sun T, Gerschenson LE (2000) DNA repair is activated in early stages of p53-induced apoptosis. Cell Death Differ 7:393–401. https://doi.org/10.1038/sj.cdd.4400663
Ghaemi SN (2006) Paradigms of psychiatry: eclecticism and its discontents. Curr Opin Psychiatry 19:619–624. https://doi.org/10.1097/01.yco.0000245751.98749.52
Gilman CP, Mattson MP (2002) Do apoptotic mechanisms regulate synaptic plasticity and growth-cone motility? NeuroMolecular Med 2:197–214. https://doi.org/10.1385/NMM:2:2:197
Glatt SJ, Everall IP, Kremen WS, Corbeil J, a ik R, Khanlou N, Han M, Liew CC, Tsuang MT (2005) Comparative gene expression analysis of blood and brain provides concurrent validation of SELENBP1 up-regulation in schizophrenia. Proc Natl Acad Sci U S A 102:15533–15538. https://doi.org/10.1073/pnas.0507666102
Glinsky GV (2009) Human genome connectivity code links disease-associated SNPs, microRNAs and pyknons. Cell Cycle 8:925–930. https://doi.org/10.4161/cc.8.6.7937
Guo X, Yang J, Huang J, Chen Z, Wu X, Zhu L, Huang G, Long J, Su L (2018) Influence of CTNNB1 rs2953 polymorphism on schizophrenia susceptibility in Chinese Han population through modifying miR-485 binding to CTNNB1. Genes Brain Behav 18:e12524. https://doi.org/10.1111/gbb.12524
Khan RA et al. (2016) Analysis of association between common variants in the SLCO6A1 gene with schizophrenia, bipolar disorder and major depressive disorder in the Han Chinese population. The world journal of biological psychiatry: the official journal of the World Federation of Societies of Biological Psychiatry 17:140–146 doi:https://doi.org/10.3109/15622975.2015.1126676
Komarova EA, Chernov MV, Franks R, Wang K, Armin G, Zelnick CR, Chin DM, Bacus SS, Stark GR, Gudkov AV (1997) Transgenic mice with p53-responsive lacZ: p53 activity varies dramatically during normal development and determines radiation and drug sensitivity in vivo. EMBO J 16:1391–1400. https://doi.org/10.1093/emboj/16.6.1391
Lajin B, Alachkar A, Michati R, Alhaj Sakur A (2013) Association between polymorphisms in the genes for tumor suppressor protein p53 and its regulator NAD(P)H: quinone oxidoreductase 1 (NQO1) and schizophrenia in a Syrian study cohort. Arch Med Res 44:121–126. https://doi.org/10.1016/j.arcmed.2012.12.009
Lee DH, Kim C, Zhang L, Lee YJ (2008) Role of p53, PUMA, and Bax in wogonin-induced apoptosis in human cancer cells. Biochem Pharmacol 75:2020–2033. https://doi.org/10.1016/j.bcp.2008.02.023
Liu S, Zhang F, Shugart YY, Yang L, Li X, Liu Z, Sun N, Yang C, Guo X, Shi J, Wang L, Cheng L, Zhang K, Yang T, Xu Y (2017) The early growth response protein 1-miR-30a-5p-neurogenic differentiation factor 1 axis as a novel biomarker for schizophrenia diagnosis and treatment monitoring. Transl Psychiatry 7:e998. https://doi.org/10.1038/tp.2016.268
Long J, Huang G, Liang W, Liang B, Chen Q, Xie J, Jiang J, Su L (2014) The prevalence of schizophrenia in mainland China: evidence from epidemiological surveys. Acta Psychiatr Scand 130:244–256. https://doi.org/10.1111/acps.12296
Luzzi S, Colleoni L, Corbetta P, Baldinelli S, Fiori C, Girelli F, Silvestrini M, Caroppo P, Giaccone G, Tagliavini F, Rossi G (2017) Missense mutation in GRN gene affecting RNA splicing and plasma progranulin level in a family affected by frontotemporal lobar degeneration. Neurobiol Aging 54(214):e211–214 e216. https://doi.org/10.1016/j.neurobiolaging.2017.02.008
Mahmood S, Evinova A, Skerenova M, Ondrejka I, Lehotsky J (2016) Association of EGF, IGFBP-3 and TP53 gene polymorphisms with major depressive disorder in Slovak population. Cent Eur J Public Health 24:223–230. https://doi.org/10.21101/cejph.a4301
Mellerup E, Andreassen OA, Bennike B, Dam H, Djurovic S, Jorgensen MB, Kessing LV, Koefoed P, Melle I, Mors O, Moeller GL (2017) Combinations of genetic variants associated with bipolar disorder. PLoS One 12:e0189739. https://doi.org/10.1371/journal.pone.0189739
Mortensen PB (1989) The incidence of cancer in schizophrenic patients. J Epidemiol Community Health 43:43–47
Mortensen PB (1994) The occurrence of cancer in first admitted schizophrenic patients. Schizophr Res 12:185–194
Ni X, Trakalo J, Valente J, Azevedo MH, Pato MT, Pato CN, Kennedy JL (2005) Human p53 tumor suppressor gene (TP53) and schizophrenia: case-control and family studies. Neurosci Lett 388:173–178. https://doi.org/10.1016/j.neulet.2005.06.050
Pan C, Wu C, Jia W, Xu Y, Lei C, Hu S, Lan X, Chen H (2013) A critical functional missense mutation (H173R) in the bovine PROP1 gene significantly affects growth traits in cattle. Gene 531:398–402. https://doi.org/10.1016/j.gene.2013.09.002
Papiol S, Arias B, Barrantes-Vidal N, Guitart M, Salgado P, Catalan R, Fananas L (2004) Analysis of polymorphisms at the tumor suppressor gene p53 (TP53) in contributing to the risk for schizophrenia and its associated neurocognitive deficits. Neurosci Lett 363:78–80. https://doi.org/10.1016/j.neulet.2004.03.049
Qiu W, Schonleben F, Thaker HM, Goggins M, Su GH (2006) A novel mutation of STK11/LKB1 gene leads to the loss of cell growth inhibition in head and neck squamous cell carcinoma. Oncogene 25:2937–2942. https://doi.org/10.1038/sj.onc.1209325
Ran LX, Zheng ZY, Xie B, Nie XM, Chen XW, Su G, Cai SJ (2018) A mouse model of a novel missense mutation (Gly83Arg) in a Chinese kindred manifesting vitreous amyloidosis only. Exp Eye Res 169:13–19. https://doi.org/10.1016/j.exer.2018.01.017
Rollins B, Martin MV, Morgan L, Vawter MP (2010) Analysis of whole genome biomarker expression in blood and brain. Am J Med Genet B, Neuropsychiatric Genet: Off Publ Int Soc Psychiatric Genet 153B:919–936. https://doi.org/10.1002/ajmg.b.31062
Rosenmann H, Meiner Z, Kahana E, Aladjem Z, Friedman G, Ben-Yehuda A, Grenader T, Wertman E, Abramsky O (2003) An association study of the codon 72 polymorphism in the pro-apoptotic gene p53 and Alzheimer’s disease. Neurosci Lett 340:29–32
Rossi M, Kilpinen H, Muona M, Surakka I, Ingle C, Lahtinen J, Hennah W, Ripatti S, Hovatta I (2014) Allele-specific regulation of DISC1 expression by miR-135b-5p. Eur J Hum Genet: EJHG 22:840–843. https://doi.org/10.1038/ejhg.2013.246
Saadatian Z, Gharesouran J, Ghojazadeh M, Ghohari-Lasaki S, Tarkesh-Esfahani N, Mohaddes Ardebili SM (2014) Association of rs1219648 in FGFR2 and rs1042522 in TP53 with premenopausal breast cancer in an Iranian Azeri population. Asian Pac J Cancer Prev: APJCP 15:7955–7958
Sagar R, Pattanayak RD (2017) Potential biomarkers for bipolar disorder: where do we stand? Indian J Med Res 145:7–16. https://doi.org/10.4103/ijmr.IJMR_1386_16
Sah VP, Attardi LD, Mulligan GJ, Williams BO, Bronson RT, Jacks T (1995) A subset of p53-deficient embryos exhibit exencephaly. Nat Genet 10:175–180. https://doi.org/10.1038/ng0695-175
Saito T, Kondo K, Iwayama Y, Shimasaki A, Aleksic B, Yamada K, Toyota T, Hattori E, Esaki K, Ujike H, Inada T, Kunugi H, Kato T, Yoshikawa T, Ozaki N, Ikeda M, Iwata N (2014) Replication and cross-phenotype study based upon schizophrenia GWASs data in the Japanese population: support for association of MHC region with psychosis. Am J Med Genet B, Neuropsychiatric Genet: Off Publ Int Soc Psychiatric Genet 165B:421–427. https://doi.org/10.1002/ajmg.b.32246
Sakhi S, Bruce A, Sun N, Tocco G, Baudry M, Schreiber SS (1994) p53 induction is associated with neuronal damage in the central nervous system. Proc Natl Acad Sci U S A 91:7525–7529
Schummer M, Thorpe J, Giraldez MD, Bergan L, Tewari M, Urban N (2015) Evaluating serum markers for hormone receptor-negative breast cancer. PLoS One 10:e0142911. https://doi.org/10.1371/journal.pone.0142911
Shi J, Gershon ES, Liu C (2008) Genetic associations with schizophrenia: meta-analyses of 12 candidate genes. Schizophr Res 104:96–107. https://doi.org/10.1016/j.schres.2008.06.016
Shi S, Leites C, He D, Schwartz D, Moy W, Shi J, Duan J (2014) MicroRNA-9 and microRNA-326 regulate human dopamine D2 receptor expression, and the microRNA-mediated expression regulation is altered by a genetic variant. J Biol Chem 289:13434–13444. https://doi.org/10.1074/jbc.M113.535203
Smit DJA, Wright MJ, Meyers JL, Martin NG, Ho YYW, Malone SM, Zhang J, Burwell SJ, Chorlian DB, de Geus EJC, Denys D, Hansell NK, Hottenga JJ, McGue M, van Beijsterveldt CEM, Jahanshad N, Thompson PM, Whelan CD, Medland SE, Porjesz B, Lacono WG, Boomsma DI (2018) Genome-wide association analysis links multiple psychiatric liability genes to oscillatory brain activity. Hum Brain Mapp 39:4183–4195. https://doi.org/10.1002/hbm.24238
Sun G, Wang Y, Zhang J, Lin N, You Y (2018) MiR-15b/HOTAIR/p53 form a regulatory loop that affects the growth of glioma cells. J Cell Biochem 119:4540–4547. https://doi.org/10.1002/jcb.26591
Tak YG, Farnham PJ (2015) Making sense of GWAS: using epigenomics and genome engineering to understand the functional relevance of SNPs in non-coding regions of the human genome. Epigenetics Chromatin 8:57. https://doi.org/10.1186/s13072-015-0050-4
Thomas M, Kalita A, Labrecque S, Pim D, Banks L, Matlashewski G (1999) Two polymorphic variants of wild-type p53 differ biochemically and biologically. Mol Cell Biol 19:1092–1100
Tian X, Dai S, Sun J, Jiang S, Jiang Y (2017) The association between the TP53 Arg72Pro polymorphism and colorectal cancer: an updated meta-analysis based on 32 studies. Oncotarget 8:1156–1165. https://doi.org/10.18632/oncotarget.13589
Tylee DS, Kawaguchi DM, Glatt SJ (2013) On the outside, looking in: a review and evaluation of the comparability of blood and brain -omes. Am J Med Genet B, Neuropsychiatric Genet: Off Publ Int Soc Psychiatric Genet 162B:595–603. https://doi.org/10.1002/ajmg.b.32150
Uribe E, Wix R (2012) Neuronal migration, apoptosis and bipolar disorder. Rev Psiquiatr Salud Mental 5:127–133. https://doi.org/10.1016/j.rpsm.2011.11.005
Wang J, Liu Q, Yuan S, Xie W, Liu Y, Xiang Y, Wu N, Wu L, Ma X, Cai T, Zhang Y, Sun Z, Li Y (2017) Genetic predisposition to lung cancer: comprehensive literature integration, meta-analysis, and multiple evidence assessment of candidate-gene association studies. Sci Rep 7:8371. https://doi.org/10.1038/s41598-017-07737-0
Wu GC, Zhang ZT (2015) Genetic association of single nucleotide polymorphisms in P53 pathway with gastric cancer risk in a Chinese Han population. Med Oncol 32:401. https://doi.org/10.1007/s12032-014-0401-1
Yang X, Klein R, Tian X, Cheng HT, Kopan R, Shen J (2004a) Notch activation induces apoptosis in neural progenitor cells through a p53-dependent pathway. Dev Biol 269:81–94. https://doi.org/10.1016/j.ydbio.2004.01.014
Yang Y, Xiao Z, Chen W, Sang H, Guan Y, Peng Y, Zhang D, Gu Z, Qian M, He G, Qin W, Li D, Gu N, He L (2004b) Tumor suppressor gene TP53 is genetically associated with schizophrenia in the Chinese population. Neurosci Lett 369:126–131. https://doi.org/10.1016/j.neulet.2004.07.068
Zhang L, Cao XL, Wang SB, Zheng W, Ungvari GS, Ng CH, Zhong BL, Wang G, Xiang YT (2017) The prevalence of bipolar disorder in China: a meta-analysis. J Affect Disord 207:413–421. https://doi.org/10.1016/j.jad.2016.08.062
Zhao W, Zhang SC, Huang WK, Li XL (2018) Mutations in Smad-interacting protein 1 gene are responsible for absence of its expression in Hirschsprung’s disease. Clin Exp Med 18:445–451. https://doi.org/10.1007/s10238-018-0496-3
Funding
This work was supported by the National Natural Science Foundation of China (No. 81460518).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of Interest
The authors declare that they have no conflict of interest.
Ethical Approval
All procedures performed in studies involving human participants were approved by the local ethical committee. The work described has been carried out in accordance with The Code of Ethics of the World Medical Association (Declaration of Helsinki).
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Jialei Yang, Xulong Wu, Jiao Huang, and Zhaoxia Chen are first co-authors.
Rights and permissions
About this article
Cite this article
Yang, J., Wu, X., Huang, J. et al. TP53 Polymorphism Contributes to the Susceptibility to Bipolar Disorder but Not to Schizophrenia in the Chinese Han Population. J Mol Neurosci 68, 679–687 (2019). https://doi.org/10.1007/s12031-019-01330-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12031-019-01330-y